NCBIO Roadmap to Diversity Event
“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center
NCBIO Members Save Big with BIO Business Solutions
BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.
NCBIO, the North Carolina Biosciences Organization
NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.
Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology.Read More
Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.Read More
On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…Read More
The 2022 NCBIO Annual Meeting held Oct. 12 at the NC Biotechnology Center featured expert panels on locating in North Carolina, talent recruitment, financial trends and health equity and disparities. The meeting returned to being fully in person this year after several years of being virtual or offering an online option due to the COVID pandemic.Read More
In this past year, we emerged from the isolation of COVID-19 thanks in no small part to the heroic work of the life sciences industry in developing vaccines, rapid tests and new treatments that have made the pandemic much more manageable. In spite of this success, we have faced tremendous pressure at the federal level with threats to intellectual property, the lifeblood of the industry, and a push to insert price controls with potential repercussions on innovation.Read More
Sen. Richard Burr reflected on his 28-year career in Congress and discussed FDA reform, the nation’s response to future pandemics and the pitfalls of the nation’s regulatory system at the 2022 NCBIO Annual Dinner held Monday, Oct. 10, at the NC Biotechnology Center.Read More
At their quarterly meeting held Wednesday, Sept. 14, members of the NCBIO Biomanufacturers Forum learned about efforts and options for bolstering workforce and talent development in North Carolina. Members also received an update on the $25 million Build Back Better awarded to expand, connect and promote training and career opportunities in North Carolina.Read More